Group 1 - Taboola will release its fourth quarter and full year 2025 financial results on February 25, 2026, at 8:30 a.m. ET [1] - A conference call and webcast will be hosted by Taboola's senior management team to discuss the financial results [1] - The webcast will be available for replay for one year, until February 25, 2027 [1] Group 2 - Taboola provides performance advertising technology that extends beyond search and social media, delivering measurable outcomes at scale [2] - The company collaborates with thousands of businesses, reaching approximately 600 million daily active users through its ad platform, Realize [3] - Major publishers like NBC News and Yahoo, as well as OEMs such as Samsung and Xiaomi, utilize Taboola's technology to enhance audience growth and revenue [3]

AS Harju Elekter Group announces a change in its shareholding structure. On 27 January 2026, KJK Fund SICAV-SIF (shares held through a nominee account at ING Luxembourg) informed AS Harju Elekter Group that its holding had decreased to 9.98%. The change in the holding results from the issuance of new Harju Elekter shares in connection with the exercise of the share option programme directed at the members of the Management Board. Tiit AtsoChairman of the Management Board+372 674 7400 ...

Nugevia™ supports metabolic, mitochondrial, and neuroinflammatory biology impacted by GLP-1-driven weight loss Jupiter, Florida, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter” or the “Company”), a clinical-stage pharmaceutical company developing JOTROL™, a patented resveratrol-based platform, today announced a strategic initiative to support individuals using GLP-1-based weight loss therapies through its Nugevia™ consumer longevity product line. This initiative reinf ...

Announces U.S. store closuresSAN FRANCISCO, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Allbirds, Inc. (NASDAQ: BIRD), a global lifestyle brand that innovates with sustainable materials to make better products in a better way, today announced actions to build a simpler and more profitable lifestyle footwear business. The Company will close its remaining full-price stores in the U.S. by the end of February 2026, enabling Allbirds to dedicate resources toward its e-commerce platform, wholesale partnerships and internat ...

INCLINE VILLAGE, Nev., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Tri Pointe Homes, Inc. (NYSE: TPH) announced today that it will release its financial results for the fourth quarter of 2025 before the market opens on Wednesday, February 25, 2026. The Company will host a conference call on the same day to discuss the results at 7:00 AM Pacific (10:00 AM Eastern). The call will be hosted by Doug Bauer, Chief Executive Officer, Tom Mitchell, Chief Operating Officer, Glenn Keeler, Chief Financial Officer, and Linda Mam ...

Approximately five million Canadian households rent their homes1; rental payments on credit reports could help millions showcase responsible payment behaviour, marking a major step forward in financial inclusion TORONTO and CALGARY, Alberta, Jan. 28, 2026 (GLOBE NEWSWIRE) -- TransUnion and Zenbase today announced a partnership to expand the availability of rental payment information within the credit reporting ecosystem, giving renters a new way to strengthen their TransUnion credit reports and broaden acce ...

VANCOUVER, British Columbia, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Skeena Resources Limited (TSX: SKE, NYSE: SKE) (“Skeena Gold & Silver”, “Skeena” or the “Company”) is pleased to announce the receipt of its British Columbia (“B.C.”) Mines Act Permit (“MA”) for the Company’s 100%-owned Eskay Creek Gold-Silver Project (“Eskay” or the “Project”) located in Northwestern B.C., Canada. The receipt of the MA builds upon B.C.’s first Section 7 Declaration Act agreement, entered into jointly with the Tahltan Central Go ...

Core Viewpoint - Constellium SE will announce its fourth quarter and full year 2025 results during a conference call on February 18, 2026, at 10:00 AM Eastern Time [1] Group 1: Conference Call Details - The conference call will be hosted by CEO Ingrid Joerg and CFO Jack Guo [1] - Details for the conference call, webcast, and accompanying presentation will be available on the Constellium Investor Relations page [2] - An archived recording of the conference call will be accessible for three weeks on the company’s website [2] Group 2: Company Overview - Constellium is a global leader in developing innovative, value-added aluminum products for various markets, including aerospace, packaging, and automotive [3] - The company generated $7.3 billion in revenue in 2024 [3]

Core Insights - Mabtech and Sai Life Sciences have formed a strategic collaboration to establish Sai's Boston laboratory as a co-marketed US execution and demonstration hub for the Mabtech EYRA™ platform [1][2] Group 1: Collaboration Details - The collaboration will jointly deliver advanced immunology assay services, including high-sensitivity multiplex cytokine and phenotyping workflows, utilizing the EYRA platform at Sai's Boston site [2] - This initiative aims to enhance access to next-generation immune profiling capabilities for biopharma and biotech companies involved in immuno-oncology, vaccines, inflammation, and cellular therapy [2][4] Group 2: Platform Features and Benefits - The EYRA platform features intuitive software, automation readiness, and the ability to simultaneously detect dozens of analytes in a single run with minimal hands-on time, addressing limitations of traditional systems [3] - The collaboration allows for the integration of advanced immune profiling into broader discovery and translational strategies, facilitating faster decision-making for discovery clients [4] Group 3: Key Elements of the Collaboration - Key elements include joint service delivery of EYRA-based immunology panels and custom assays, co-branded demonstrations and pilot programs at Sai Boston, shared thought leadership, and integrated business development engagement [7]

DXS INTERNATIONAL PLC (AQSE: DXSP) HALF YEAR RESULTS DXS International plc ("DXS" or the "Company"), the digital clinical decision support company, is pleased to provide shareholders with its unaudited interim results for the half year ending 31 October 2025. H1 2025 Financial highlights: Core recurring revenue model remains resilient. Revenue decreased by 2.6% to £1,684,712 (H1 2024 - £1,730,829) in the six months to 31 October 2025 ("Period"). Administration costs decreased by 5% in the Period (H1 2024 - ...